Actively Recruiting
TRU-Cut Biopsy in Tumor cHaracterisation
Led by General University Hospital, Prague · Updated on 2025-02-10
250
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Tru-cut biopsy (TCB) is a minimally invasive method to get an adequate sample from the lesion in order to tailor the appropriate management avoiding unnecessary surgery. The aim of our trial is to evaluate the adequacy, accuracy and safety of the method related to the final histology as reference standard.
CONDITIONS
Official Title
TRU-Cut Biopsy in Tumor cHaracterisation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Presence of a pelvic or abdominal lesion suspected to be malignant
- New diagnosis of a presumed gynecologic tumor
- Suspicious recurrence or progression of a known gynecologic malignancy
- Pelvic or abdominal spread or recurrence of a non-gynecologic tumor (primary tumor or metastasis)
- Pelvic or abdominal spread of a tumor of unknown origin
- Age 18 years or older
- Eastern Cooperative Oncology Group (ECOG) performance status less than 3
- Not pregnant
- Signed informed consent form
You will not qualify if you...
- Considered unsuitable for any treatment by the investigator
- Early stage disease
- Age younger than 18 years
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Gynecology, Obstetrics and Neonatology of First Faculty of Medicine and General University Hospital in Prague
Prague, Czechia, 12800
Actively Recruiting
Research Team
R
Renata Poncová, MD.
CONTACT
F
Filip Frühauf, MD.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here